HS

Himani Shah

Himani Shah


Seasoned Compliance Leader Driving Global Operational Excellence



Professional Overview
Himani Shah is a distinguished compliance executive with over 15 years of experience driving strategic initiatives and operational excellence across the pharmaceutical industry. As the Vice President, Head of Global Compliance Operations, Programs & Monitoring at Alnylam Pharmaceuticals, she oversees the development and implementation of comprehensive compliance programs that ensure organizational integrity and mitigate regulatory risks.

Experience Summary

Current Role
As the Vice President, Head of Global Compliance Operations, Programs & Monitoring at Alnylam Pharmaceuticals, Himani is responsible for leading a team of compliance professionals in establishing robust policies, procedures, and monitoring systems to uphold the company's commitment to ethical and compliant business practices. She spearheads the development and optimization of compliance programs, driving continuous improvement and alignment with evolving industry regulations.

Career Progression
Prior to her current role, Himani served as the Interim Vice President, Head of Alexion Compliance at Alexion Pharmaceuticals, where she oversaw the integration of compliance systems and processes following Alexion's acquisition by AstraZeneca. As the Executive Director, Head of Global Compliance Operations at Alexion, she implemented innovative compliance strategies and enhanced the company's operational efficiency.

Himani's earlier career included progressive roles within the Global Compliance Department at AstraZeneca, where she held positions as the Head of Global Policy & Risk and Senior Director. In these roles, she successfully led cross-functional initiatives to strengthen compliance frameworks and mitigate regulatory risks. Prior to her in-house experience, Himani served as an Associate in the Food & Drug Practice Group at Covington & Burling LLP, where she provided legal counsel and compliance guidance to pharmaceutical and biotechnology clients.

Academic Background
Himani holds a Juris Doctor (J.D.) degree from the University of Pennsylvania Law School, where she demonstrated academic excellence and engagement in regulatory and compliance-focused coursework.

Areas of Expertise
  • Compliance program development and optimization

  • Global policy and risk management

  • Regulatory compliance and monitoring

  • Cross-functional collaboration and stakeholder engagement

  • Strategic planning and operational efficiency


Professional Impact
Recognized for her strategic vision and operational acumen, Himani has consistently delivered impactful results throughout her career. At Alexion Pharmaceuticals, she led the successful integration of compliance systems and processes following the company's acquisition, ensuring a seamless transition and maintaining regulatory compliance. At AstraZeneca, Himani spearheaded the development of innovative compliance strategies that enhanced the company's global operations and mitigated regulatory risks.

Conclusion
Himani Shah's extensive experience and demonstrated expertise in global compliance operations, program development, and risk management position her as a valuable asset to Alnylam Pharmaceuticals. Her strategic leadership, operational excellence, and commitment to ethical business practices make her a trusted advisor in navigating the evolving compliance landscape within the pharmaceutical industry.